PTC Therapeutics Future Growth
How is PTC Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Future Growth Score
1/6Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
48.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,009 | -134 | 109 | -101 | 6 |
12/31/2024 | 955 | -202 | -39 | -118 | 12 |
12/31/2023 | 903 | -321 | -144 | -175 | 13 |
9/30/2022 | 697 | -531 | -409 | -260 | N/A |
6/30/2022 | 618 | -556 | -422 | -273 | N/A |
3/31/2022 | 569 | -522 | -395 | -249 | N/A |
12/31/2021 | 539 | -524 | -337 | -251 | N/A |
9/30/2021 | 492 | -455 | -327 | -247 | N/A |
6/30/2021 | 472 | -391 | -250 | -169 | N/A |
3/31/2021 | 430 | -454 | -271 | -213 | N/A |
12/31/2020 | 381 | -438 | -250 | -194 | N/A |
9/30/2020 | 358 | -441 | -193 | -140 | N/A |
6/30/2020 | 311 | -432 | -221 | -182 | N/A |
3/31/2020 | 322 | -292 | -198 | -138 | N/A |
12/31/2019 | 307 | -252 | -144 | -99 | N/A |
9/30/2019 | 297 | -222 | -142 | -104 | N/A |
6/30/2019 | 279 | -213 | -116 | -85 | N/A |
3/31/2019 | 262 | -181 | -72 | -54 | N/A |
12/31/2018 | 265 | -128 | -43 | -28 | N/A |
9/30/2018 | 256 | -78 | 0 | 9 | N/A |
6/30/2018 | 245 | -61 | -91 | -10 | N/A |
3/31/2018 | 224 | -69 | -78 | 3 | N/A |
12/31/2017 | 194 | -79 | -90 | -10 | N/A |
9/30/2017 | 142 | -107 | -124 | -45 | N/A |
6/30/2017 | 123 | -108 | -55 | -53 | N/A |
3/31/2017 | 90 | -130 | -93 | -91 | N/A |
12/31/2016 | 83 | -142 | -105 | -104 | N/A |
9/30/2016 | 70 | -166 | -122 | -121 | N/A |
6/30/2016 | 57 | -174 | N/A | -124 | N/A |
3/31/2016 | 48 | -174 | N/A | -129 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PTCT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PTCT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PTCT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PTCT's revenue (10.7% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: PTCT's revenue (10.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PTCT is forecast to be unprofitable in 3 years.